S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate

PHASE3CompletedINTERVENTIONAL
Enrollment

619

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Precancerous/Nonmalignant ConditionProstate Cancer
Interventions
DRUG

L-selenomethionine

Randomization between active L-selenomethionine and placebo

DRUG

L-selenomethionine placebo

Randomization between active L-selenomethionine and placebo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

Cancer and Leukemia Group B

NETWORK

lead

SWOG Cancer Research Network

NETWORK

NCT00030901 - S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | Biotech Hunter | Biotech Hunter